Clinical Trial Update: A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer [Phase 2]

View source ↗

Summary

AstraZeneca is conducting a Phase 2 trial evaluating novel interventions and combinations for metastatic colorectal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING